Crohn disease Trials in Los Angeles, United States
Conditions / Crohn disease / Los Angeles, United States
Clinical trials for Crohn disease investigate a range of treatment strategies and patient populations.
34 total trials for this combination
Showing top 10 of 34 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03440372 | Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT03723447 | Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) | COMPLETED | PHASE4 |
| NCT02596893 | Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT03051204 | OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome | COMPLETED | — |
| NCT03440385 | Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT03467958 | An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |
| NCT00261976 | A Long-term Safety Study of Infliximab (Remicade) | COMPLETED | — |
| NCT03798405 | Reactive vs. Proactive Pain Control in IBD | TERMINATED | NA |
| NCT07196722 | A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | RECRUITING | PHASE2/PHASE3 |
| NCT03464097 | A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease | TERMINATED | PHASE3 |